quinazolines has been researched along with ficusin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Lu, Q; Sun, X; Wei, X; Yao, Z; Zhang, D; Zhang, X; Zhang, Z | 1 |
| Beyer, WF; Gooden, D; Liu, L; Soderblom, EJ; Spector, NL; Toone, EJ; Walder, H; Xia, W; Zhao, S | 1 |
2 other study(ies) available for quinazolines and ficusin
| Article | Year |
|---|---|
[Comparison of 4 extraction methods of chemical constituents in medicinal tea sishen chaji].
Topics: Cyclooctanes; Drug Combinations; Drugs, Chinese Herbal; Ficusin; Lignans; Plant Extracts; Polycyclic Compounds; Quinazolines; Technology, Pharmaceutical | 1997 |
Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catalytic Domain; Cell Line, Tumor; Cell Nucleus; Cross-Linking Reagents; Drug Resistance, Neoplasm; Female; Ficusin; Humans; Lapatinib; Molecular Targeted Therapy; Protein Kinase Inhibitors; PUVA Therapy; Quinazolines; Quinolines; Receptor, ErbB-2; Signal Transduction; Ultraviolet Rays | 2014 |